David C. Yeomans
Chief Scientist
pharmaceutical
PainCeptor Pharma Corporation
Canada
Biography
David C. Yeomans working as Chief Scientist PainCeptor Pharma Corporation Dr. David C. Yeomans, Ph.D., also known as Dave, founded Trigemina, Inc. in 2006 and serves as its Chief Scientist. Dr. Yeomans is the Director Pain Research and a tenured Associate Professor of Anesthesia at Stanford University School of Medicine. He serves as an Advisor of SiteOne, Inc. He is the chair of the scientific advisory board of three companies and an advisor to numerous pharmaceutical and biotech companies, as well as venture capital firms and intellectual property law practices. Dr. Yeomans serves as a Member of Scientific Advisory Board of PainCeptor Pharma Corporation. He has authored over 60 peer reviewed articles and 11 book chapters in the field of pain, and has been the recipient of numerous NIH grants. He has authored 9 patent applications and co-founded 2 companies devoted to the management of pain. Dr. Yeomans earned an AB degree from Dartmouth College, received his PhD in Neuroscience from the University of Florida, and completed his research training as a NIH fellow at the University of Illinois.
Research Interest
pharmaceutical and biotech